Yeh, C., Chang, Y., Su, Y., Hsu, S.-S., Cheng, C., Wu, R., … Chen, M. (2017). Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients. Oncotarget, 8(69), 113444-113459. https://doi.org/10.18632/oncotarget.23049 (Original work published 2017)